Maternal diet and infant leukemia: A role DNA topoisomerase ii inhibitors?

International Journal of Cancer

Volumn 78, Issue SUPPL. 11, 1998, Pages 26-28

  Ross, Julie A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; PESTICIDE; SOLVENT;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 11; DIET; DRUG ANTAGONISM; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENETICS; HUMAN; INFANT; INTERVIEW; PREGNANCY; RISK FACTOR; ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; HIGH RISK POPULATION; INFANT DISEASE; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 11; DIET; DNA TOPOISOMERASES, TYPE II; FEMALE; GENES; HUMANS; INFANT; INTERVIEWS; LEUKEMIA, MYELOCYTIC, ACUTE; MATERNAL EXPOSURE; PREGNANCY; RISK FACTORS;

EID: 0032246492     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(1998)78:11+<26::aid-ijc8>3.0.co;2-m     Document Type: Article

References (21)

1. BERNARD, O.A. and BERGER, R., Molecular basis of 1 Iq23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer, 13, 75-85 (1995).
2. CHEN, H. and EASTMOND, D.A., Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. Carcinogenesis, 16,2301-2307 (1995).
3. CIMINO, G., RAPANOTTI, M.C., BIONDI, A., ELIA, L., Lo Coco, F., PRICE, C., Rossi, V., RIVOLTA, A., CANAANI, E., CROCE, C.M., MANDELLI, F. and GREAVES, M., Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res., 57,2879-2883 (1997).
4. CONSTANTINOU, A., SlONER, G.D., NlEHTA, R., RAO, K., RUNYAN, C. and MOON, R., The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Nulr. Cancer, 23, 121-130(1995).
5. DJABALI, M., SELLERI, L., PARRY, P., BOWER, M., YOUNG, B.D. and EVANS, G.A., A trithorax-like gene is interrupted by chromosome 1 Iq23 translocations in acute leukemias. Nature (Genet), 2,113-118 (1992).
6. FELIX, C.A., HOSLER, M.R., WINICK, N.J., MASTERSON, M., WILSON, A.E. and LANGE, B.J., ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 85,3250-3256 (1995).
7. FORD, A.M., RIDGE, S.A., CABRERA, M.E., MAHMOUD, H., STEEL, C.M., CHAN, L.C. and GREAVES, M., In utero rearrangements in the trithoraxrelated oncogene in infant leukemias. Nature (Land.), 363,358-360 (1993).
8. GERWITZ, D.A., Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase ll inhibitors? Biochem. Plmrmacol, 42, 2253-2258(1991).
9. GREAVES, M.F., Aetiology of acute leukemia. Lancet, 349,344-349 (1997).
10. GURNEY, J.G., Ross, J.A., WALL, D.A., BLEYER, W.A., SEVERSON, R.K. and ROBISON, L.L., Infant cancer in the United States: histology-specific incidence and trends, 1973-1992. J. pediatr. Hematol. Oncol, 19,428-432 (1997).
11. GURNEY, J.G., SEVERSON, R.K., DAVIS, S. and ROBISON, L.L., Incidence of cancer in children in the United States. Cancer, 75,2186-2195 (1995).
12. LARSON, R.A., LEBEAU, M.M., VARDIMAN, J.W. and ROWLEY, J.D., Myeloid leukemia after hematoloxins. Em-iron. Health Perspect., 104, 1303-1307 (1996).
13. PARKIN, D.M., STILLER, C.A., DRAPER, G.J., BIEBER, C.A., TERRACINI, B. and YOUNG, J.L. (eds.), International incidence of childhood cancer, IARC Publication 87, International Agency for Research on Cancer, Lyon (1988).
14. PUI, C.-H., BEHM, F.G., RAIMONDI, S.C., DODGE, R.K., GEORGE, S.L., RIVERA, O.K., MIRRO, J., KALWIXSKY, O.K., DAHL, G.V. and MURPHY, S.B., Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N. Engl. J. Med, 321,136-142 (1989).
15. ROBISON, L.L., BUCKLEY, J.D. and BUNIN, G., Assessment of environmental and genetic factors in the etiology of childhood cancers: the Children's Cancer Group epidemiology program. Environ. Health Perspect., 6, 111-116(1995).
16. ROSS, J.A., DAVIES, S.M., POTTER, J.D. and ROBISON, L.L., Childhood leukemia with a focus on infants. Epidemiol. Rev., 16,243-272 (1994
17. ROSS, J.A., POTTER, J.D., REAMAN, G.H., PENDERGRASS, T.W. and ROBISON, L.L., Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control, 7,581-590 (1996).
18. ROSS, J.A., POTTER, J.D. and ROBISON, L.L., Infant leukemia, topoisomerase II inhibitors, and the MIL gene. J. not. Cancer Inst., 86, 1678-1680 (19946).
19. ROSS, J.A., POTTER, J.D., SHU, X.O., REAMAN, G.H., LAMPKIN, B. and ROBISON, L.L., Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the Children's Cancer Group. Ann. Epidemiol., 7,172-179 (1997).
20. TURLEY, H., COMLEY, M., HOULBROOK, S., NOZAKI, N., KlKUCHI, A., HICKSON, I.D., GATTER, K. and HARRIS, A.L., The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Brit. J. Cancer, 75,1340-1346 (1997).
21. YEAZEL, M.W., BUCKLEY, J.D., WOODS, W.G., RUCCIONE, K. and ROBISON, L.L., History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Children's Cancer Group. Cancer, 75,1718-1727 (1995).